Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
+9.11%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$44.2B
AUM Growth
+$2.04B
(+4.8%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.66%
Top 10 Holdings %
Top 10 Hldgs %
6.77%
Holding
3,372
New
440
Increased
1,162
Reduced
1,295
Closed
329
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$251M |
| 2 |
Bank of America
BAC
|
+$226M |
| 3 |
JD.com
JD
|
+$216M |
| 4 |
KLA
KLAC
|
+$203M |
| 5 |
CVS Health
CVS
|
+$196M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 2 |
Meta Platforms (Facebook)
META
|
+$282M |
| 3 |
PayPal
PYPL
|
+$248M |
| 4 |
Goldman Sachs
GS
|
+$240M |
| 5 |
Amazon
AMZN
|
+$233M |
Sector Composition
| 1 | Technology | 18.27% |
| 2 | Healthcare | 14.05% |
| 3 | Financials | 13.35% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Discretionary | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Endava
DAVA
$543M
| $570K | ﹤0.01% |
22,300
+5,300
| +31% | +$135K |
|
2302
Mersana Therapeutics
MRSN
$36.7M
| $567K | ﹤0.01% |
12,009
-17,939
| -60% | -$848K |
|
2303
IBM
IBM
$239B
| $567K | ﹤0.01% |
2,566
-3,724
| -59% | -$823K |
|
2304
Vivid Seats
SEAT
$96.5M
| $567K | ﹤0.01% |
7,665
-11,868
| -61% | -$878K |
|
|
SSBK
2305
DELISTED
Southern States Bancshares
SSBK
| $567K | ﹤0.01% |
18,445
-1,274
| -6% | -$39.2K |
|
2306
Invesco Golden Dragon China ETF
PGJ
$157M
| $566K | ﹤0.01% |
+20,071
| New | +$566K |
|
2307
LSB Industries
LXU
$585M
| $565K | ﹤0.01% |
70,331
+11,783
| +20% | +$94.7K |
|
2308
Enliven Therapeutics
ELVN
$1.14B
| $564K | ﹤0.01% |
22,080
+4,843
| +28% | +$124K |
|
|
MAGN
2309
Magnera Corporation
MAGN
$404M
| $561K | ﹤0.01% |
23,982
+4,906
| +26% | +$115K |
|
|
AZUL
2310
DELISTED
Azul
AZUL
| $561K | ﹤0.01% |
+163,070
| New | +$561K |
|
2311
Capricor Therapeutics
CAPR
$289M
| $560K | ﹤0.01% |
36,793
+12,882
| +54% | +$196K |
|
2312
Aehr Test Systems
AEHR
$795M
| $557K | ﹤0.01% |
43,348
-291,295
| -87% | -$3.74M |
|
|
WAY
2313
Waystar Holding Corp
WAY
$6.68B
| $557K | ﹤0.01% |
+19,968
| New | +$557K |
|
2314
CytomX Therapeutics
CTMX
$345M
| $556K | ﹤0.01% |
471,468
-190,479
| -29% | -$225K |
|
2315
Potbelly
PBPB
$515M
| $556K | ﹤0.01% |
66,638
-68,535
| -51% | -$572K |
|
2316
Clarus
CLAR
$149M
| $553K | ﹤0.01% |
122,913
+30,379
| +33% | +$137K |
|
|
MREO
2317
Mereo BioPharma
MREO
$283M
| $552K | ﹤0.01% |
134,313
-67,463
| -33% | -$277K |
|
2318
Global X Genomics & Biotechnology ETF
GNOM
$46.6M
| $551K | ﹤0.01% |
+12,250
| New | +$551K |
|
2319
Village Super Market
VLGEA
$550M
| $551K | ﹤0.01% |
17,339
-8,868
| -34% | -$282K |
|
2320
Superior Group of Companies
SGC
$187M
| $549K | ﹤0.01% |
35,466
+19,970
| +129% | +$309K |
|
|
LAR
2321
Lithium Argentina AG
LAR
$513M
| $549K | ﹤0.01% |
+168,320
| New | +$549K |
|
2322
Equinox Gold
EQX
$8.58B
| $548K | ﹤0.01% |
+90,044
| New | +$548K |
|
2323
Textron
TXT
$14.4B
| $547K | ﹤0.01% |
6,177
-3,319
| -35% | -$294K |
|
2324
Clearwater Analytics
CWAN
$5.82B
| $547K | ﹤0.01% |
21,654
-59,724
| -73% | -$1.51M |
|
|
SMR.WS
2325
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
| $545K | ﹤0.01% |
171,314
+32,007
| +23% | +$102K |
|